205 related articles for article (PubMed ID: 23912956)
1. Associations with growth factor genes (FGF1, FGF2, PDGFB, FGFR2, NRG2, EGF, ERBB2) with breast cancer risk and survival: the Breast Cancer Health Disparities Study.
Slattery ML; John EM; Stern MC; Herrick J; Lundgreen A; Giuliano AR; Hines L; Baumgartner KB; Torres-Mejia G; Wolff RK
Breast Cancer Res Treat; 2013 Aug; 140(3):587-601. PubMed ID: 23912956
[TBL] [Abstract][Full Text] [Related]
2. Associations of polymorphisms in the genes of FGFR2, FGF1, and RBFOX2 with breast cancer risk by estrogen/progesterone receptor status.
Cen YL; Qi ML; Li HG; Su Y; Chen LJ; Lin Y; Chen WQ; Xie XM; Tang LY; Ren ZF
Mol Carcinog; 2013 Nov; 52 Suppl 1():E52-9. PubMed ID: 23143756
[TBL] [Abstract][Full Text] [Related]
3. The influence of genetic ancestry and ethnicity on breast cancer survival associated with genetic variation in the TGF-β-signaling pathway: The Breast Cancer Health Disparities Study.
Slattery ML; Lundgreen A; Stern MC; Hines L; Wolff RK; Giuliano AR; Baumgartner KB; John EM
Cancer Causes Control; 2014 Mar; 25(3):293-307. PubMed ID: 24337772
[TBL] [Abstract][Full Text] [Related]
4. Replication of five GWAS-identified loci and breast cancer risk among Hispanic and non-Hispanic white women living in the Southwestern United States.
Slattery ML; Baumgartner KB; Giuliano AR; Byers T; Herrick JS; Wolff RK
Breast Cancer Res Treat; 2011 Sep; 129(2):531-9. PubMed ID: 21475998
[TBL] [Abstract][Full Text] [Related]
5. Energy homeostasis genes and survival after breast cancer diagnosis: the Breast Cancer Health Disparities Study.
Pellatt AJ; Lundgreen A; Wolff RK; Hines L; John EM; Slattery ML
Cancer Causes Control; 2016 Jan; 27(1):47-57. PubMed ID: 26472474
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase genes are associated with breast cancer risk and survival: the Breast Cancer Health Disparities Study.
Slattery ML; John E; Torres-Mejia G; Stern M; Lundgreen A; Hines L; Giuliano A; Baumgartner K; Herrick J; Wolff RK
PLoS One; 2013; 8(5):e63165. PubMed ID: 23696797
[TBL] [Abstract][Full Text] [Related]
7. Associations between genetic variants in the TGF-β signaling pathway and breast cancer risk among Hispanic and non-Hispanic white women.
Boone SD; Baumgartner KB; Baumgartner RN; Connor AE; Pinkston CM; John EM; Hines LM; Stern MC; Giuliano AR; Torres-Mejia G; Brock GN; Groves FD; Kerber RA; Wolff RK; Slattery ML
Breast Cancer Res Treat; 2013 Sep; 141(2):287-97. PubMed ID: 24036662
[TBL] [Abstract][Full Text] [Related]
8. Genetic variation in bone morphogenetic proteins and breast cancer risk in hispanic and non-hispanic white women: The breast cancer health disparities study.
Slattery ML; John EM; Torres-Mejia G; Herrick JS; Giuliano AR; Baumgartner KB; Hines LM; Wolff RK
Int J Cancer; 2013 Jun; 132(12):2928-39. PubMed ID: 23180569
[TBL] [Abstract][Full Text] [Related]
9. Gene-based analysis of the fibroblast growth factor receptor signaling pathway in relation to breast cancer in African American women: the AMBER consortium.
Ruiz-Narváez EA; Haddad SA; Lunetta KL; Yao S; Bensen JT; Sucheston-Campbell LE; Hong CC; Haiman CA; Olshan AF; Ambrosone CB; Palmer JR
Breast Cancer Res Treat; 2016 Jan; 155(2):355-63. PubMed ID: 26743380
[TBL] [Abstract][Full Text] [Related]
10. Associations between ALOX, COX, and CRP polymorphisms and breast cancer among Hispanic and non-Hispanic white women: The breast cancer health disparities study.
Connor AE; Baumgartner RN; Baumgartner KB; Pinkston CM; Boone SD; John EM; Torres-Mejía G; Hines LM; Giuliano AR; Wolff RK; Slattery ML
Mol Carcinog; 2015 Dec; 54(12):1541-53. PubMed ID: 25339205
[TBL] [Abstract][Full Text] [Related]
11. Hormone-dependent effects of FGFR2 and MAP3K1 in breast cancer susceptibility in a population-based sample of post-menopausal African-American and European-American women.
Rebbeck TR; DeMichele A; Tran TV; Panossian S; Bunin GR; Troxel AB; Strom BL
Carcinogenesis; 2009 Feb; 30(2):269-74. PubMed ID: 19028704
[TBL] [Abstract][Full Text] [Related]
12. Genetic variants in interleukin genes are associated with breast cancer risk and survival in a genetically admixed population: the Breast Cancer Health Disparities Study.
Slattery ML; Herrick JS; Torres-Mejia G; John EM; Giuliano AR; Hines LM; Stern MC; Baumgartner KB; Presson AP; Wolff RK
Carcinogenesis; 2014 Aug; 35(8):1750-9. PubMed ID: 24670917
[TBL] [Abstract][Full Text] [Related]
13. Energy homeostasis genes and breast cancer risk: The influence of ancestry, body size, and menopausal status, the breast cancer health disparities study.
Slattery ML; Lundgreen A; Hines L; Wolff RK; Torres-Mejia G; Baumgartner KN; John EM
Cancer Epidemiol; 2015 Dec; 39(6):1113-22. PubMed ID: 26395295
[TBL] [Abstract][Full Text] [Related]
14. Associations between ALDH1A1 polymorphisms, alcohol consumption, and mortality among Hispanic and non-Hispanic white women diagnosed with breast cancer: the Breast Cancer Health Disparities Study.
Xia Z; Baumgartner KB; Baumgartner RN; Boone SD; Hines LM; John EM; Wolff R; Slattery ML; Connor AE
Breast Cancer Res Treat; 2018 Apr; 168(2):443-455. PubMed ID: 29190005
[TBL] [Abstract][Full Text] [Related]
15. Angiogenesis genes, dietary oxidative balance and breast cancer risk and progression: the Breast Cancer Health Disparities Study.
Slattery ML; John EM; Torres-Mejia G; Lundgreen A; Lewinger JP; Stern MC; Hines L; Baumgartner KB; Giuliano AR; Wolff RK
Int J Cancer; 2014 Feb; 134(3):629-44. PubMed ID: 23832257
[TBL] [Abstract][Full Text] [Related]
16. VEGF, FGF1, FGF2 and EGF gene polymorphisms and psoriatic arthritis.
Butt C; Lim S; Greenwood C; Rahman P
BMC Musculoskelet Disord; 2007 Jan; 8():1. PubMed ID: 17204151
[TBL] [Abstract][Full Text] [Related]
17. IL6, aspirin, nonsteroidal anti-inflammatory drugs, and breast cancer risk in women living in the southwestern United States.
Slattery ML; Curtin K; Baumgartner R; Sweeney C; Byers T; Giuliano AR; Baumgartner KB; Wolff RR
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):747-55. PubMed ID: 17416766
[TBL] [Abstract][Full Text] [Related]
18. Allele-specific regulation of FGFR2 expression is cell type-dependent and may increase breast cancer risk through a paracrine stimulus involving FGF10.
Huijts PE; van Dongen M; de Goeij MC; van Moolenbroek AJ; Blanken F; Vreeswijk MP; de Kruijf EM; Mesker WE; van Zwet EW; Tollenaar RA; Smit VT; van Asperen CJ; Devilee P
Breast Cancer Res; 2011 Jul; 13(4):R72. PubMed ID: 21767389
[TBL] [Abstract][Full Text] [Related]
19. Genetic variation in the JAK/STAT/SOCS signaling pathway influences breast cancer-specific mortality through interaction with cigarette smoking and use of aspirin/NSAIDs: the Breast Cancer Health Disparities Study.
Slattery ML; Lundgreen A; Hines LM; Torres-Mejia G; Wolff RK; Stern MC; John EM
Breast Cancer Res Treat; 2014 Aug; 147(1):145-58. PubMed ID: 25104439
[TBL] [Abstract][Full Text] [Related]
20. Diet and lifestyle factors interact with MAPK genes to influence survival: the Breast Cancer Health Disparities Study.
Slattery ML; Hines LH; Lundgreen A; Baumgartner KB; Wolff RK; Stern MC; John EM
Cancer Causes Control; 2014 Sep; 25(9):1211-25. PubMed ID: 24993294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
